Biology of IDH mutant cholangiocarcinoma
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Hepatology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.32424
Reference154 articles.
1. Cholangiocarcinoma—evolving concepts and therapeutic strategies;Nat Rev Clin Oncol,2018
2. The implications of IDH mutations for cancer development and therapy;Nat Rev Clin Oncol,2021
3. Comprehensive molecular profiling of intra‐ and extrahepatic cholangiocarcinomas: potential targets for intervention;Clin Cancer Res,2018
4. Oncometabolite 2‐hydroxyglutarate is a competitive inhibitor of α‐ketoglutarate‐dependent dioxygenases;Cancer Cell,2011
5. 2‐Oxoglutarate‐dependent dioxygenases in cancer;Nat Rev Cancer,2020
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Isocitrate dehydrogenases 2-mediated dysfunctional metabolic reprogramming promotes intestinal cancer progression via regulating HIF-1A signaling pathway;International Immunopharmacology;2024-10
2. Emerging biomarkers for immunotherapy response in biliary tract cancers: a comprehensive review of immune checkpoint inhibitor strategies;Biomarkers in Medicine;2024-08-15
3. Targeting Isocitrate Dehydrogenase (IDH) in Solid Tumors: Current Evidence and Future Perspectives;Cancers;2024-08-02
4. The effect of genetics and biochemistry on the pathogenesis of cholangiocarcinoma;International Journal of Hepatobiliary and Pancreatic Diseases;2024-07-25
5. Tubulocystic Carcinoma of Bile Ducts;American Journal of Surgical Pathology;2024-07-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3